Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix (ZOE-50) Efficacy in Adults Aged 50 Years or Older
NCT01165177Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2010
- Primary completion
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 18
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Aug 2010; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01165177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165177.